Recombinant ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) decreases vascular calcification and prevents osteomalacia in a rat model of chronic kidney disease.

Saved in:
Bibliographic Details
Title: Recombinant ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) decreases vascular calcification and prevents osteomalacia in a rat model of chronic kidney disease.
Authors: O'Brien K; Research and Development, Inozyme Pharma, Boston, MA 02210, United States., Laurion L; Research and Development, Inozyme Pharma, Boston, MA 02210, United States., Sullivan C; Research and Development, Inozyme Pharma, Boston, MA 02210, United States., Howe J; Research and Development, Inozyme Pharma, Boston, MA 02210, United States., Lynch AM, Cheng Z, Schrier D; Research and Development, Inozyme Pharma, Boston, MA 02210, United States., Husson H; Research and Development, Inozyme Pharma, Boston, MA 02210, United States., Sabbagh Y; Research and Development, Inozyme Pharma, Boston, MA 02210, United States.
Source: JBMR plus [JBMR Plus] 2025 Apr 16; Vol. 9 (6), pp. ziaf065. Date of Electronic Publication: 2025 Apr 16 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101707013 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4039 (Electronic) Linking ISSN: 24734039 NLM ISO Abbreviation: JBMR Plus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40390805
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Recombinant ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) decreases vascular calcification and prevents osteomalacia in a rat model of chronic kidney disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22O'Brien+K%22">O'Brien K</searchLink>; Research and Development, Inozyme Pharma, Boston, MA 02210, United States.<br /><searchLink fieldCode="AU" term="%22Laurion+L%22">Laurion L</searchLink>; Research and Development, Inozyme Pharma, Boston, MA 02210, United States.<br /><searchLink fieldCode="AU" term="%22Sullivan+C%22">Sullivan C</searchLink>; Research and Development, Inozyme Pharma, Boston, MA 02210, United States.<br /><searchLink fieldCode="AU" term="%22Howe+J%22">Howe J</searchLink>; Research and Development, Inozyme Pharma, Boston, MA 02210, United States.<br /><searchLink fieldCode="AU" term="%22Lynch+AM%22">Lynch AM</searchLink><br /><searchLink fieldCode="AU" term="%22Cheng+Z%22">Cheng Z</searchLink><br /><searchLink fieldCode="AU" term="%22Schrier+D%22">Schrier D</searchLink>; Research and Development, Inozyme Pharma, Boston, MA 02210, United States.<br /><searchLink fieldCode="AU" term="%22Husson+H%22">Husson H</searchLink>; Research and Development, Inozyme Pharma, Boston, MA 02210, United States.<br /><searchLink fieldCode="AU" term="%22Sabbagh+Y%22">Sabbagh Y</searchLink>; Research and Development, Inozyme Pharma, Boston, MA 02210, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101707013%22">JBMR plus</searchLink> [JBMR Plus] 2025 Apr 16; Vol. 9 (6), pp. ziaf065. <i>Date of Electronic Publication: </i>2025 Apr 16 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101707013 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-4039 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734039%22">24734039 </searchLink><i>NLM ISO Abbreviation: </i>JBMR Plus <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40390805
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jbmrpl/ziaf065
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: ziaf065
    Titles:
      – TitleFull: Recombinant ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) decreases vascular calcification and prevents osteomalacia in a rat model of chronic kidney disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: O'Brien K
      – PersonEntity:
          Name:
            NameFull: Laurion L
      – PersonEntity:
          Name:
            NameFull: Sullivan C
      – PersonEntity:
          Name:
            NameFull: Howe J
      – PersonEntity:
          Name:
            NameFull: Lynch AM
      – PersonEntity:
          Name:
            NameFull: Cheng Z
      – PersonEntity:
          Name:
            NameFull: Schrier D
      – PersonEntity:
          Name:
            NameFull: Husson H
      – PersonEntity:
          Name:
            NameFull: Sabbagh Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 04
              Text: 2025 Apr 16
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2473-4039
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: JBMR plus
              Type: main
ResultId 1